Page - 92 - in Cancer Nanotheranostics - What Have We Learnd So Far?

Conniotet al. Nanocarriers for immunecell targetingand tracking Santra, S., andMalhotra, A. (2011). Fluorescent nanoparticle probes for imaging of cancer.Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3, 501–510. doi: 10.1002/wnan.134 Schlosser, E., Mueller, M., Fischer, S., Basta, S., Busch, D. H., Gander, B., et al. (2008). TLR ligands and antigen need to be coencapsulated into the same biodegradablemicrosphereforthegenerationofpotentcytotoxicTlymphocyte responses.Vaccine26,1626–1637.doi:10.1016/j.vaccine.2008.01.030 Schreiber,R.D.,Old,L. J., andSmyth,M. J. (2011).Cancer immunoediting: inte- grating immunity’s roles in cancer suppression and promotion. Science 331, 1565–1570.doi:10.1126/science.1203486 Sen, D., Deerinck, T. J., Ellisman,M.H., Parker, I., and Cahalan,M. D. (2008). Quantumdots for tracking dendritic cells and priming an immune response invitroand invivo.PLoSONE3:e3290.doi:10.1371/journal.pone.0003290 Settles,M.,Etzrodt,M.,Kosanke,K., Schiemann,M.,Zimmermann,A.,Meier,R., et al. (2011).Different capacityofmonocyte subsets tophagocytose iron-oxide nanoparticles.PLoSONE6:e25197.doi:10.1371/journal.pone.0025197 Shahar, E., Gorodetsky, R., Gaberman, E., Aizenshtein, E., and Pitcovski, J. (2010). Targeted microbeads for attraction and induction of specific innate immuneresponse inthetumormicroenvironment.Vaccine28,7279–7287.doi: 10.1016/j.vaccine.2010.08.083 Shankaran,V., Ikeda,H.,Bruce,A.T.,White, J.M., Swanson,P.E.,Old,L. J., et al. (2001). IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.Nature 410, 1107–1111. doi: 10.1038/350 74122 Sharma,A., Jain,N., andSareen,R. (2013).Nanocarriers fordiagnosis and target- ingofbreast cancer.BiomedRes. Int.2013:960821.doi:10.1155/2013/960821 Sharp, F.A., Ruane,D.,Claass, B.,Creagh, E.,Harris, J.,Malyala, P., et al. (2009). Uptake of particulate vaccine adjuvants bydendritic cells activates theNALP3 inflammasome.Proc. Natl. Acad. Sci. U.S.A. 106, 870–875. doi: 10.1073/pnas. 0804897106 Shen, H., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., et al. (2006). Enhanced and prolonged cross-presentation following endoso- malescapeofexogenousantigensencapsulated inbiodegradablenanoparticles. Immunology117,78–88.doi:10.1111/j.1365-2567.2005.02268.x Shen,L.,Higuchi,T.,Tubbe, I.,Voltz,N.,Krummen,M.,Pektor,S., etal. (2013).A trifunctionaldextran-basednanovaccine targetsandactivatesmurinedendritic cells, and inducespotentcellularandhumoral immuneresponses invivo.PLoS ONE8:e80904.doi:10.1371/journal.pone.0080904 Shi,H.,He,X.,Yuan,Y.,Wang,K.,andLiu,D.(2010).Nanoparticle-basedbiocom- patibleandlong-lifemarkerfor lysosomelabelingandtracking.Anal.Chem.82, 2213–2220.doi:10.1021/ac902417s Shields, J.D.,Kourtis, I.C.,Tomei,A.A.,Roberts, J.M., andSwartz,M.A. (2010). Inductionof lymphoidlike stromaand immune escapeby tumors that express thechemokineCCL21.Science328,749–752.doi:10.1126/science.1185837 Shime, H., Matsumoto, M., Oshiumi, H., Tanaka, S., Nakane, A., Iwakura, Y., et al. (2012).Toll-like receptor 3 signaling converts tumor-supportingmyeloid cells to tumoricidal effectors.Proc.Natl.Acad. Sci.U.S.A.109, 2066–2071. doi: 10.1073/pnas.1113099109 Shimizu,K.,Mizuno,T., Shinga, J.,Asakura,M.,Kakimi,K., Ishii,Y., et al. (2013). Vaccinationwithantigen-transfected,NKTcell ligand-loaded,humancellselic- its robust in situ immune responses by dendritic cells.Cancer Res. 73, 62–73. doi:10.1158/0008-5472.CAN-12-0759 Shubayev, V. I., Pisanic, T. R. 2nd., and Jin, S. (2009). Magnetic nanoparticles for theragnostics.Adv.DrugDeliv. Rev. 61, 467–477. doi: 10.1016/j.addr.2009. 03.007 Sica,A., andMantovani,A. (2012).Macrophageplasticityandpolarization: invivo veritas. J.Clin. Invest.122,787–795.doi:10.1172/JCI59643 Sica,A., Schioppa,T.,Mantovani,A., andAllavena, P. (2006). Tumour-associated macrophages are a distinctM2 polarised population promoting tumour pro- gression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717–727. doi:10.1016/j.ejca.2006.01.003 Silva, J.M.,Videira,M.,Gaspar,R., Preat,V., andFlorindo,H.F. (2013). Immune systemtargetingbybiodegradablenanoparticles for cancervaccines. J.Control. Release168,179–199.doi:10.1016/j.jconrel.2013.03.010 Sims,G.P.,Rowe,D.C.,Rietdijk,S.T.,Herbst,R.,andCoyle,A. J. (2010).HMGB1 andRAGEin inflammationandcancer.Annu.Rev. Immunol.28,367–388.doi: 10.1146/annurev.immunol.021908.132603 Singh,R., andLillard, J.W. Jr. (2009).Nanoparticle-based targeteddrugdelivery. Exp.Mol.Pathol.86,215–223.doi:10.1016/j.yexmp.2008.12.004 Slovin, S. F., Ragupathi, G., Musselli, C., Olkiewicz, K., Verbel, D., Kuduk, S. D., et al. (2003). Fully synthetic carbohydrate-based vaccines in biochemically relapsedprostatecancer:clinicaltrialresultswithalpha-N-acetylgalactosamine- O-serine/threonine conjugate vaccine. J. Clin. Oncol. 21, 4292–4298. doi: 10.1200/JCO.2003.04.112 Smirnov, P., Lavergne, E., Gazeau, F., Lewin, M., Boissonnas, A., Doan, B. T., et al. (2006). In vivo cellular imaging of lymphocyte trafficking by MRI: a tumormodelapproach tocell-basedanticancer therapy.Magn.Reson.Med.56, 498–508.doi:10.1002/mrm.20996 Smith, P. J.,Giroud,M.,Wiggins,H. L.,Gower, F., Thorley, J. A., Stolpe, B., et al. (2012). Cellular entry of nanoparticles via serum sensitive clathrin-mediated endocytosis, and plasmamembrane permeabilization. Int. J. Nanomedicine 7, 2045–2055.doi:10.2147/IJN.S29334 Sosnovik, D. E., and Nahrendorf, M. (2012). Cells and iron oxide nanoparti- cles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarc- tion.Circ. Cardiovasc. Imaging 5, 551–554. doi: 10.1161/CIRCIMAGING.112. 978932 Sperling,R.A.,andParak,W.J.(2010).Surfacemodification,functionalizationand bioconjugationofcolloidal inorganicnanoparticles.Philos.Trans.AMath.Phys. Eng.Sci.368,1333–1383.doi:10.1098/rsta.2009.0273 Spranger,S., Spaapen,R.M.,Zha,Y.,Williams, J.,Meng,Y.,Ha,T.T., et al. (2013). Up-regulation of PD-L1, IDO, andT(regs) in themelanoma tumormicroen- vironment is driven by CD8(+) T cells. Sci. Transl. Med. 5, 200ra116. doi: 10.1126/scitranslmed.3006504 Srinivas,M.,Boehm-Sturm,P.,Figdor,C.G.,DeVries, I. J., andHoehn,M.(2012). Labelingcells for invivo trackingusing(19)FMRI.Biomaterials33,8830–8840. doi:10.1016/j.biomaterials.2012.08.048 Srinivas,M.,Turner,M. S., Janjic, J.M.,Morel, P.A., Laidlaw,D.H., andAhrens, E.T. (2009). Invivocytometryof antigen-specific t cellsusing19FMRI.Magn. Reson.Med.62,747–753.doi:10.1002/mrm.22063 Stelter, L., Pinkernelle, J. G., Michel, R., Schwartlander, R., Raschzok, N., Morgul,M. H., et al. (2010).Modification of aminosilanized superparamag- netic nanoparticles: feasibility of multimodal detection using 3TMRI, small animal PET, and fluorescence imaging. Mol. Imaging Biol. 12, 25–34. doi: 10.1007/s11307-009-0237-9 Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., and Irvine, D. J. (2010). Therapeutic cell engineeringwith surface-conjugated synthetic nanoparticles. Nat.Med.16,1035–1041.doi:10.1038/nm.2198 Swann, J. B., and Smyth,M. J. (2007). Immune surveillance of tumors. J. Clin. Invest.117,1137–1146.doi:10.1172/JCI31405 Tagami, T., Foltz, W. D., Ernsting, M. J., Lee, C. M., Tannock, I. F., May, J. P., et al. (2011). MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensi- tive liposome. Biomaterials 32, 6570–6578. doi: 10.1016/j.biomaterials.2011. 05.029 Tanaka, E., Choi, H. S., Fujii, H., Bawendi, M. G., and Frangioni, J. V. (2006). Image-guided oncologic surgery using invisible light: completed pre- clinical development for sentinel lymphnodemapping.Ann. Surg.Oncol. 13, 1671–1681.doi:10.1245/s10434-006-9194-6 Tari, A., Khodadadian, M., Ellerson, D., Deisseroth, A., and Lopez-Berestein, G. (1996). Liposomal delivery of oligodeoxynucleotides. Leuk. Lymphoma 21, 93–97.doi:10.3109/10428199609067585 Thiele, L.,Merkle,H.P., andWalter, E. (2003).Phagocytosis andphagosomal fate of surface-modifiedmicroparticles indendritic cells andmacrophages.Pharm. Res.20,221–228.doi:10.1023/A:1022271020390 Thomas,L. (1982).Onimmunosurveillance inhumancancer.Yale J.Biol.Med.55, 329–333. Thorek, D. L., and Tsourkas, A. (2008). Size, charge and concentration depen- dent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29, 3583–3590.doi:10.1016/j.biomaterials.2008.05.015 Thu,M. S., Bryant, L.H., Coppola, T., Jordan, E.K., Budde,M.D., Lewis, B. K., et al. (2012). Self-assemblingnanocomplexes by combining ferumoxytol, hep- arinandprotamine forcell trackingbymagnetic resonance imaging.Nat.Med. 18,463–467.doi:10.1038/nm.2666 Thu,M. S., Najbauer, J., Kendall, S. E., Harutyunyan, I., Sangalang, N., Gutova, M.,etal. (2009). Ironlabelingandpre-clinicalMRIvisualizationof therapeutic humanneural stem cells in amurine gliomamodel. PLoSONE 4:e7218. doi: 10.1371/journal.pone.0007218 www.frontiersin.org November2014 |Volume2 |Article105 | 92